Geneva Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7M	Buy	21,243 +4,091	+24%	+$337K	0.04%	112
2025 Q4	$1.46M	Buy	17,152 +3,201	+23%	+$263K	0.03%	120
2025 Q3	$1.08M	Sell	13,951 -528	-4%	-$41.3K	0.02%	121
2025 Q2	$1.13M	Sell	14,479 -483	-3%	-$36K	0.02%	122
2025 Q1	$1.08M	Sell	14,962 -268	-2%	-$19.2K	0.02%	123
2024 Q4	$1.13M	Sell	15,230 -1,092	-7%	-$76.4K	0.02%	128
2024 Q3	$1.08M	Sell	16,322 -1,415	-8%	-$103K	0.02%	129
2024 Q2	$1.64M	Sell	17,737 -4,421	-20%	-$391K	0.03%	125
2024 Q1	$2.12M	Sell	22,158 -1,104	-5%	-$92.7K	0.04%	120
2023 Q4	$1.77M	Sell	23,262 -1,165	-5%	-$81.1K	0.03%	121
2023 Q3	$1.69M	Sell	24,427 -9,378	-28%	-$754K	0.04%	120
2023 Q2	$3.19M	Sell	33,805 -1,423	-4%	-$124K	0.06%	111
2023 Q1	$2.91M	Sell	35,228 -2,622	-7%	-$206K	0.06%	112
2022 Q4	$2.82M	Buy	37,850 +1,289	+4%	+$99.3K	0.06%	114
2022 Q3	$3.02M	Sell	36,561 -12	-0%	-$1.16K	0.07%	116
2022 Q2	$3.48M	Sell	36,573 -403	-1%	-$41.7K	0.08%	112
2022 Q1	$4.35M	Buy	36,976 +420	+1%	+$47.1K	0.08%	113
2021 Q4	$4.74M	Sell	36,556 -893	-2%	-$104K	0.08%	114
2021 Q3	$4.24M	Sell	37,449 -1,083	-3%	-$124K	0.07%	114
2021 Q2	$3.99M	Sell	38,532 -167	-0.4%	-$15.7K	0.07%	115
2021 Q1	$3.24M	Buy	38,699 +4,529	+13%	+$383K	0.06%	119
2020 Q4	$3.12M	Buy	34,170 +36	+0.1%	+$2.99K	0.05%	120
2020 Q3	$2.73M	Buy	34,134 +309	+0.9%	+$24.1K	0.06%	116
2020 Q2	$2.34M	Buy	33,825 +300	+0.9%	+$21.3K	0.05%	115
2020 Q1	$2.11M	Buy	+33,525	New	+$2.42M	0.06%	115
2013 Q4	–	Sell	-3,055,296	Closed	-$35.5M	–	137
2013 Q3	$35.5M	Sell	3,055,296 -1,329,936	-30%	-$15.6M	0.84%	55
2013 Q2	$49.1M	Buy	+4,385,232	New	+$51.9M	0.98%	51